Cancer mortality following treatment for adult hyperthyroidism

JAMA

Volumn 280, Issue 4, 1998, Pages 347-355

  Ron, Elaine ^a   Doody, Michele Morin ^a   Becker, David V ^b   Brill, A Bertrand ^c   Curtis, Rochelle E ^a   Goldman, Marlene B ^d   Harris III, Benjamin S H ^e   Hoffman, Daniel A ^f   McConahey, William M ^g   Maxon, Harry R ^h   Preston Martin, Susan ⁱ   Warshauer, M Ellen ^b   Wong, F Lennie ^a,j   Boice, John D ^a,k  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e RTI INTERNATIONAL   (United States)

^f GEORGE WASHINGTON UNIVERSITY   (United States)

^g MAYO CLINIC   (United States)

^h UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^j International Epidemiology Institute ^*

^k INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; IODINE 131;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER MORTALITY; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; KIDNEY CARCINOMA; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; THYROID CARCINOMA; THYROTOXICOSIS; TOXIC GOITER;

EID: 0032578119     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.280.4.347     Document Type: Article

References (39)

1. Furszyfer J, Kurland LT, McConahey WM, et al. Epidemiologic aspects of Hashimoto's thyroiditis and Graves' disease in Rochester, Minnesota, 1935-1967. Metabolism. 1972;21:197-204.
2. Tunbridge WMG, Evered DD, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol. 1977;7:481-493.
3. Volpé R. Graves' disease. In: Burrow GN, Oppenheimer JH, Volpé R, eds. Thyroid Function and Disease. Philadelphia, Pa: WB Saunders Co; 1989: 214-260.
4. Klein I, Becker DV, Levey GS. Treatment of hyperthyroid disease. Ann Intern Med. 1994;121:281-288.
5. Saenger EL, Thoma GE, Tompkins EA. Incidence of leukemia following treatment of hyperthyroidism. JAMA. 1968;205:855-862.
6. I. In: Radiation Associated Thyroid Carcinoma. New York, NY: Grune & Stratton; 1977:459-483.
7. Halnan KE. Risks from radioiodine treatment of thyrotoxicosis. BMJ. 1983;287:8121-8122.
8. Graham GD, Burman KD. Radioiodine treatment of Graves' disease. Ann Intern Med. 1986;105: 900-905.
9. Becker DV. Comparison of iodine-131 therapy and alternative treatments of hyperthyroidism. In: Nagataki S, ed. Radiation and the Thyroid. Tokyo, Japan: Excerpta Medica Ltd; 1989:57-67.
10. Dobyns BM, Sheline GE, Workman JB, et al. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism. J Clin Endocrinol Metab. 1974;38:976-998.
11. Hoffman DA, McConahey WM, Diamond EL, Kurland LT. Mortality in women treated for hyperthyroidism. Am J Epidemiol. 1982;115:243-253.
12. Goldman MB, Monson RR, Maloof F. Cancer mortality in women with thyroid disease. Cancer Res. 1990;50:2283-2289.
13. Hoffman DA, McConahey WM, Fraumeni JF, Kurland LT. Cancer incidence following treatment of hyperthyroidism. Int J Epidemiol. 1982;11:218-224.
14. Goldman MB, Maloof F, Monson RR, et al. Radioactive iodine therapy and breast cancer. Am J Epidemiol. 1988;127:969-980.
15. Hall P, Berg G, Bjelkengren G, et al. Cancer mortality after iodine-131 therapy for hyperthyroidism. Int J Cancer. 1992;50:886-890.
16. Becker DV, McConahey WM, Dobyns BM, et al. The results of radioiodine treatment of hyperthyroidism. In: Fellinger K, Höfer R, eds. Further Advances in Thyroid Research. Vienna, Austria: Verlage der wiener Medizinischen Akademie; 1971: 603-609.
17. Tompkins E. Late effects of radioiodine therapy. In: Cloutier RJ, Edwards CL, Snyder WS, eds. Medical Radionuclides: Radiation Dose and Effects. Washington, DC: Atomic Energy Commission; 1970:431-440.
18. Manual of the International Classification of Diseases, Eighth Revision Adapted for Use in the United States. Washington, DC: US Dept of Health, Education, and Welfare; 1967. PHS publication 1693.
19. Manual of the International Statistical Classification of Diseases, Seventh Revision. Geneva, Switzerland: World Health Organization; 1957.
20. Monson RR. Analysis of relative survival and proportional mortality. Comput Biomed Res. 1974; 7:325-332.
21. International Commission on Radiological Protection. Radiation dose to patients from radiopharmaceuticals. Ann ICRP. 1988;18:275-278.
22. Becker DV, Hurley JR. Radioiodine treatment of hyperthyroidism. In: Sandler MA, Patton JA, Coleman RE, eds. Diagnostic Nuclear Medicine. 3rd ed. Baltimore, Md: Williams & Wilkins; 1996:943-958.
23. Loevinger R, Holt JG, Hine GJ. Internally administered radioisotopes. In: Hine GJ, Brownwell GL, eds. Radiation Dosimetry. New York, NY: Academic Press Inc; 1956:870.
24. 131I therapy of thyrotoxicosis. BMJ. 1961;1:210-215.
25. Zanzonico PB, Becker DV, Brill AB, et al. Extrathyroidal absorbed doses in radioiodine treatment of hyperthyroidism. JNucl Med. 1989;30:833.
26. Cox DR, Hinkley DV. Theoretical Statistics. London, England: Chapman & Hall; 1974.
27. Preston DL, Lubin JH, Pierce DA. Epicure User's Guide. Seattle, Wash: HiroSoft International Corp; 1993.
28. Williams ED. Relation between 131-therapy for thyrotoxicosis and development of thyroid carcinoma. Lancet. 1986;2:456-457.
29. Hancock BW, Bing RF, Dirmikis SM, et al. Thyroid carcinoma and concurrent hyperthyroidism. Cancer. 1977;39:298-302.
30. Ron E, Kleinerman RA, Boice JD, et al. A population-based case-control study of thyroid cancer. J Natl Cancer Inst. 1987;79:1-12.
31. Franceschi S, Fassina A, Talamini R, et al. Risk factors for thyroid cancer in North Italy. Int J Epidemiol. 1989;18:578-584.
32. Maxon HR, Thomas SR, Saenger EL, et al. Ionizing irradiation and the induction of clinically significant disease in the human thyroid. Am J Med. 1977;63:967-969.
33. Glöbel B, Glöbel H, Oberhausen E. Epidemiologic studies on patients with iodine-131 diagnostic and therapy. In: Kaul A, Neider R, Pensko J, eds. Radiation Risk Protection. Cologne, Germany: Koun; 1989:565-568.
34. Holm LE, Wiklund KE, Lundell GE, et al. Thyroid cancer after diagnostic doses of Iodine-131. J Natl Cancer Inst. 1988;80:1132-1138.
35. Holm LE, Hall P, Wiklund K, et al. Cancer risk afteriodine-131 therapy for hyperthyroidism. J Natl Cancer Inst. 1991;83:1072-1077.
36. Hall P, Holm LE, Lundell G, et al. Cancer risks in thyroid-cancer patients. Br J Cancer. 1991;4:159-163.
37. Hall P, Mattsson AP, Boice JD. Thyroid cancer after diagnostic administration of iodine-131. Radiat Res. 1996;145:86-92.
38. Shore RE. Issues and epidemiological evidence regarding radiation-induced thyroid cancer. Radiat Res. 1992;131:98-111.
39. Ron E, Lubin JH, Shore RE, et al. Thyroid cancer following exposure to external radiation. Radiat Res. 1995;141:255-273.